Étude de la variabilité de réponse à l’aspirine et au clopidogrel : résistance clinique et/ou biologique ?

Zimmerman, 2008, Clinical implications of aspirin resistance, Thromb Haemost, 100, 379, 10.1160/TH08-01-0056 De Miguel, 2008, Clinical implications of clopidogrel resistance, Thromb Haemost, 100, 196, 10.1160/TH08-01-0049 Gladding, 2008, Antiplatelet drug non responsiveness, Am Heart J, 155, 591, 10.1016/j.ahj.2007.12.034 Patrono, 2008, American College of Chest Physicians. Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), Chest, 133, 199S, 10.1378/chest.08-0672 Gaussem, 2005, The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies, J Thromb Haemost, 3, 1437, 10.1111/j.1538-7836.2005.01468.x Graff, 2007, Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers, J Thromb Haemost, 5, 2376, 10.1111/j.1538-7836.2007.02782.x Brass, 2003, Thrombin and platelet activation, Chest, 124, 18S, 10.1378/chest.124.3_suppl.18S Lind, 1991, The bleeding time does not predict surgical bleeding, Blood, 77, 2947, 10.1182/blood.V77.12.2547.2547 Rodgers, 1990, A critical reappraisal of the bleeding time, Semin Thromb Hemost, 16, 1, 10.1055/s-2007-1002658 Gachet, 2005, La variabilité interindividuelle de la réponse au Clopidogrel, Arch Mal Coeur Vaiss, 98, 216 Agarwal, 2006, Quantifying the effect of antiplatelet therapy. A comparison of the PFA-100 and modified thromboelastography (mTEG) with light transmission platelet aggregometry, Anesthesiology, 105, 676, 10.1097/00000542-200610000-00011 Varenhorst, 2009, Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin, Am Heart J, 157, 10.1016/j.ahj.2008.11.021 Blindt, 2007, The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis, Thromb Haemost, 98, 1329, 10.1160/TH07-05-0324 Jakubowski, 2008, A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry, Thromb Haemost, 99, 215, 10.1160/TH07-09-0555 Braun, 2008, Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease, Thromb Haemost, 100, 626, 10.1160/TH08-05-0313 Frère, 2007, ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcome in non-ST elevation acute coronary syndrome, Thromb Haemost, 98, 838, 10.1160/TH07-04-0296 Morel, 2007, Évaluation de la réponse plaquettaire au clopidrogrel au cours des syndromes coronariens. Comparaison de l’agrégométrie à l’ADP et de la méthode VASP, Ann Cardiol Angeiol, 56, 21, 10.1016/j.ancard.2006.11.005 Barragan, 2003, Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation, Catheter Cardiovasc Interv, 59, 295, 10.1002/ccd.10497 Mega, 2009, Cytochrome P-450 polymorphisms and response to clopidogrel, N Engl J Med, 360, 354, 10.1056/NEJMoa0809171 Collet, 2009, Cytochome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study, Lancet, 373, 309, 10.1016/S0140-6736(08)61845-0 Simon, 2009, Genetic determinants of response to clopidogrel and cardiovascular events, N Engl J Med, 360, 363, 10.1056/NEJMoa0808227 Gillard, 2008, Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study, J Am Coll Cardiol, 51, 25 Tafreschi, 2006, Combination of clopidogrel and statins: a hypothetical interaction or therapeutic dilemma?, Pharmacotherapy, 26, 388, 10.1592/phco.26.3.388 Hagihara, 2008, Comparison of human cytochrome p450 inhibition by the thienopyridines prasugrel, clopidogrel, and ticlopidine, Drug Metab Pharmacokinet, 23, 412, 10.2133/dmpk.23.412 Wiviott, 2007, Prasugrel versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 357, 2001, 10.1056/NEJMoa0706482 Mariani, 2009, Efficacy and safety of prasugrel compared with clopidogrel in patients with acute coronary syndromes: results of TRITON-TIMI 38 trials, Expert Rev Cardiovasc Ther, 7, 17, 10.1586/14779072.7.1.17 Montalescot et al. Quotidien du Médecin, 2009, p. 7.